A strategy involving a combination of VV‐IL‐24 and luteolin that could effectively suppress tumor growth or decrease toxicity may provide a potentially promising treatment for liver cancer compared with standard treatments such as chemotherapy, radiation therapy and surgical resection. Here, IL24 is linked to liver cancer.